AI Mood Market: Stock Dashboard

Company: Anavex Life Sciences Corporation

Sector: Healthcare

Industry: Biotechnology

Country: USA

Exchange: NASD

Index: RUT

P/E: -

EPS (ttm): -0.46

Insider Own: 3.23%

Shs Outstand: 92.67M

Perf Week: 4.96%

Market Cap: 274.31M

Forward P/E: -

EPS next Y: -0.14

Insider Trans: 0.00%

Shs Float: 89.68M

Perf Month: -37.82%

Enterprise Value: 142.56M

PEG: -

EPS next Q: -0.07

Inst Own: 41.08%

Short Float: 23.65%

Perf Quarter: -19.57%

Income: -39.95M

P/S: -

EPS this Y: 39.52%

Inst Trans: 6.53%

Short Ratio: 13.33

Perf Half Y: -67.58%

Sales: 0.00M

P/B: 2.17

EPS next Y Percentage: 56.43%

ROA: -31.08%

Short Interest: 21.21M

Perf YTD: -16.85%

Book/sh: 1.37

P/C: 2.08

EPS next 5Y: -

ROE: -33.63%

52W High: 13.99 -78.84%

Perf Year: -63.86%

Cash/sh: 1.42

P/FCF: -

EPS past 3/5Y: 4.47% -3.79%

ROIC: -31.55%

52W Low: 2.61 13.41%

Perf 3Y: -62.00%

Dividend Est.: -

EV/EBITDA: -

Sales past 3/5Y: - -

Gross Margin: -

Volatility W: 5.43%

Volatility M: 7.17%

Perf 5Y: -80.38%

Dividend TTM: -

EV/Sales: -

EPS Y/Y TTM: 15.81%

Oper. Margin: -

ATR (14): 0.31

Perf 10Y: -45.89%

Dividend Ex-Date: -

Quick Ratio: 20.87

Sales Y/Y TTM: -

Profit Margin: -

RSI (14): 32.53

Recom: 1.00

Dividend Gr. 3/5Y: - -

Current Ratio: 20.87

EPS Q/Q: 55.32%

SMA20: -23.29%

Beta: 1.27

Target Price: 22.00

Payout: -

Debt/Eq: 0.00

Sales Q/Q: -

SMA50: -29.43%

Rel Volume: 0.63

Prev Close: 2.99

Employees: 34

LT Debt/Eq: 0.00

Earnings: Feb 09 BMO

SMA200: -57.38%

Avg Volume: 1.59M

Price: 2.96

IPO: Aug 02, 2006

Option/Short: Yes / Yes

EPS/Sales Surpr.: 51.34% -

Trades:

Volume: 1,003,480

Change: -1.00%

AI Market Mood: Stock Dashboard

AVXL

Fundamental

Technical:

Latest News:

Annovis Bio (NYSE: ANVS) to Present at H.C. Wainwright 26th Annual Global Investment Conference neutral

ANVS AVXL LGVN